NCT06115018 The Efficacy and Maintain Effect of OPR on OSA Patients After Palatal Surgery
| NCT ID | NCT06115018 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Yi-Ju, Lai |
| Condition | Obstructive Sleep Apnea |
| Study Type | INTERVENTIONAL |
| Enrollment | 90 participants |
| Start Date | 2024-05-17 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 90 participants in total. It began in 2024-05-17 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to evaluate the maintain effect of palatal surgery and oropharyngeal rehabilitation (OPR) by using the severity of obstructive sleep apnea (OSA), tongue muscle strength and the space of the upper airway in patients with OSA.The main questions it aims to answer are: 1. Will the severity of OSA, tongue muscle strength and the space of upper airway improve more in the palatal surgery combined OPR group than the other two groups? 2. Will The maintain effect of tongue muscle strength and the space of upper airway be better in the palatal surgery combined OPR group? Participants will be divided into 3 groups including palatal surgery combined OPR group, palatal surgery group and OPR group by the doctor's advice and their willingness.The OPR for the treatment groups included three 30-minute sessions of OPR per day, and the exercise would be performed 3-5 days per week for 3 months.
Eligibility Criteria
Inclusion Criteria: * mild to severe obstructive sleep apnea patients Exclusion Criteria: * Chronic rhinosinusitis with nasal polyps * Adenoidal hypertrophy * Bilateral tonsile hypertrophy * Morbid Obesity * Drug or alcohol abuse in one year * Pregnancy * Severe lung disease * Heart disease with high risk of exercise * Neuromuscular disease that can't follow the exercise program * Central or mixed sleep apnea
Contact & Investigator
Yi-Ju Lai, PhD
PRINCIPAL INVESTIGATOR
National Cheng Kung University
Frequently Asked Questions
Who can join the NCT06115018 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Obstructive Sleep Apnea. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06115018 currently recruiting?
Yes, NCT06115018 is actively recruiting participants. Contact the research team at 11208035@gs.ncku.edu.tw for enrollment information.
Where is the NCT06115018 trial being conducted?
This trial is being conducted at Tainan, Taiwan.
Who is sponsoring the NCT06115018 clinical trial?
NCT06115018 is sponsored by Yi-Ju, Lai. The principal investigator is Yi-Ju Lai, PhD at National Cheng Kung University. The trial plans to enroll 90 participants.